BMO expects Trump to pick a more conventional FDA commissioner after RFK Jr.’s nomination

Share

Evan David Seigerman, BMO, joins ‘Fast Money’ to talk what Trump appointments mean for the biotech and pharma sectors.

05:13

38 minutes ago

Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *